Cardioprotective Effects of Pitavastatin on Cardiac Performance and Remodeling in Failing Rat Hearts
Author(s) -
Naohiko Kobayashi,
Hiroshi Takeshima,
Hiroki Fukushima,
Wataru Koguchi,
Yasuhiro Mamada,
Hirokuni Hirata,
Y. Machida,
Motoo Shinoda,
Norihiro Suzuki,
Fumie Yokotsuka,
Kaoru Tabei,
H Matsuoka
Publication year - 2008
Publication title -
american journal of hypertension
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.009
H-Index - 136
eISSN - 1941-7225
pISSN - 0895-7061
DOI - 10.1038/ajh.2008.333
Subject(s) - wortmannin , enos , pitavastatin , medicine , protein kinase b , pi3k/akt/mtor pathway , endocrinology , phosphorylation , pharmacology , nitric oxide synthase , signal transduction , nitric oxide , statin , microbiology and biotechnology , biology
Activation of phosphatidylinositol 3-kinase (PI3K)-Akt signaling by statins increases the activity of endothelial nitric oxide synthase (eNOS). We investigate whether statins (pitavastatin) improve cardiac function and remodeling via eNOS production associated with the PI3K-Akt signaling pathway, Rho-kinase (ROCK) pathway, and the development of oxidative stress in Dahl salt-sensitive (DS) hypertensive rats with heart failure (DSHF).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom